Commercial, rather than patient interests, often drive cancer care and research and patients deserve better, argue a group of global oncologists and patient advocates in a Comment published in The Lancet Oncology journal. The authors also establish core guidelines for the development of a new patient-centred movement in cancer care - Common Sense Oncology. The Comment says there has been a shift over the past few decades from predominantly publicly funded clinical trials designed to answer questions important to patients, to industry-funded trials which aim to achieve regulatory approval or commercial advantage.

https://www.miragenews.com/cancer-experts-urging-patient-centered-care-not-1047657/

#miragenews